Canaccord Genuity Group upgraded shares of $Aurora Cannabis (ACB.US)$ from a sell rating to a hold rating in a report released on Wednesday, MarketBeat.com reports.
A number of other analysts also recently issued reports on ACB. Piper Sandler cut their price target on shares of Aurora Cannabis from $4.00 to $3.00 and set a neutral rating for the company in a report on Wednesday. Stifel Nicolaus upgraded shares of Aurora Cannabis from a sell rating to a hold rating and set a $2.15 price target for the company in a report on Monday, June 6th. Canaccord Genuity Group upgraded shares of Aurora Cannabis from a sell rating to a hold rating in a report on Wednesday. Finally, Cantor Fitzgerald upgraded shares of Aurora Cannabis from a neutral rating to an overweight rating in a report on Friday, June 24th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, Aurora Cannabis currently has an average rating of Hold and a consensus target price of $4.30.
Get Aurora Cannabis alerts:
Aurora Cannabis Stock Down 1.6 %
ACB stock opened at $1.20 on Wednesday. The company has a market cap of $272.16 million, a price-to-earnings ratio of -0.20 and a beta of 2.64. The company has a current ratio of 5.13, a quick ratio of 4.76 and a debt-to-equity ratio of 0.36. Aurora Cannabis has a 12 month low of $1.12 and a 12 month high of $8.69. The firm has a 50-day moving average of $1.52 and a two-hundred day moving average of $2.20.
Hedge Funds Weigh In On Aurora Cannabis
Hedge funds have recently made changes to their positions in the stock. Dimensional Fund Advisors LP boosted its position in shares of Aurora Cannabis by 78.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 667,099 shares of the company's stock worth $3,609,000 after purchasing an additional 292,222 shares during the period. Seven Eight Capital LP boosted its position in Aurora Cannabis by 25.1% in the 4th quarter. Seven Eight Capital LP now owns 337,344 shares of the company's stock valued at $1,825,000 after buying an additional 67,621 shares during the period. Gotham Asset Management LLC purchased a new position in Aurora Cannabis in the 4th quarter valued at approximately $64,000. F3Logic LLC boosted its position in Aurora Cannabis by 104.3% in the 1st quarter. F3Logic LLC now owns 41,920 shares of the company's stock valued at $167,000 after buying an additional 21,400 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. boosted its position in Aurora Cannabis by 2.7% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,615,895 shares of the company's stock valued at $6,464,000 after buying an additional 42,423 shares during the period. Hedge funds and other institutional investors own 29.53% of the company's stock.
Aurora Cannabis Company Profile
(Get Rating)
Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.
Read More
Get a free copy of the StockNews.com research report on Aurora Cannabis (ACB)
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
MarketBeat: Week in Review 9/19 – 9/23
Why Does Tesla Stock Remain Resilient?
Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
2 Semiconductor Stocks To Watch For Reversals
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
